Antihypertensive Drugs Market Report by Therapeutic Class (Diuretics, ACE Inhibitors, Calcium Channel Blockers, Beta-adrenergic Blockers, Vasodilators, and Others), Type (Primary Hypertension, Secondary Hypertension), Distribution Channel (Retail Pharmacy, Hospital Pharmacy, E-Commerce), and Region 2024-2032
The global antihypertensive drugs market size reached US$ 29.7 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 38.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.7% during 2024-2032. The increasing prevalence of hypertension, rising number of patients suffering from CVDs, and the growing number of clinical studies represent some of the key factors driving the market.
Antihypertensive drugs are utilized to treat hypertension wherein the force of blood against the walls of the arteries becomes high and can increase the risk of heart disease, stroke, and other health problems. They generally comprise diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators. They work by relaxing the blood vessels, reducing the amount of fluid in the blood vessels, and decreasing the amount of hormones that cause blood vessels to constrict. They also slow down the heartbeat, maintain a healthy systolic BP, improve life expectancy, and minimize the risk of premature death. At present, key players are introducing imidazolines, monatepil, and neutral endopeptidase inhibitors to expand their product portfolio.
Antihypertensive Drugs Market Trends:
The surging prevalence of hypertension and high BP among individuals represents one of the major factors driving the demand for antihypertensive drugs around the world. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is influencing the market positively. In addition, the increasing number of patients suffering from cardiovascular diseases (CVDs) on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses is favoring the growth of the market. Apart from this, governing agencies of numerous countries are initiating campaigns to spread awareness about the hypertension disorder, its symptoms, diagnosis, and treatment. This, coupled with the rising number of clinical studies and trials to develop new treatments for hypertension, is strengthening the growth of the market. Furthermore, the growing usage of over the counter (OTC) drugs to treat BP-related diseases on account of expanding healthcare costs is creating a positive outlook for the market. Besides this, there is a rise in the number of online retail platforms that offer antihypertensive drugs according to the dosage needed by the consumer. This, along with significant growth in the pharmaceutical and e-commerce industries, is propelling the growth of the market. Additionally, the increasing adoption of health insurance policies that provide financial assistance for hypertension treatment and minimize healthcare expenses is impelling the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutic class, type and distribution channel.
Therapeutic Class Insights:
Type Insights:
Distribution Channel Insights:
Regional Insights:
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global antihypertensive drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
Antihypertensive drugs are utilized to treat hypertension wherein the force of blood against the walls of the arteries becomes high and can increase the risk of heart disease, stroke, and other health problems. They generally comprise diuretics, beta-blockers, calcium channel blockers, angiotensin-converting enzyme (ACE) inhibitors, and vasodilators. They work by relaxing the blood vessels, reducing the amount of fluid in the blood vessels, and decreasing the amount of hormones that cause blood vessels to constrict. They also slow down the heartbeat, maintain a healthy systolic BP, improve life expectancy, and minimize the risk of premature death. At present, key players are introducing imidazolines, monatepil, and neutral endopeptidase inhibitors to expand their product portfolio.
Antihypertensive Drugs Market Trends:
The surging prevalence of hypertension and high BP among individuals represents one of the major factors driving the demand for antihypertensive drugs around the world. Moreover, the growing geriatric population that is susceptible to developing these medical disorders is influencing the market positively. In addition, the increasing number of patients suffering from cardiovascular diseases (CVDs) on account of sedentary lifestyles, unhealthy dietary patterns, high-stress levels, diabetes, and obesity among the masses is favoring the growth of the market. Apart from this, governing agencies of numerous countries are initiating campaigns to spread awareness about the hypertension disorder, its symptoms, diagnosis, and treatment. This, coupled with the rising number of clinical studies and trials to develop new treatments for hypertension, is strengthening the growth of the market. Furthermore, the growing usage of over the counter (OTC) drugs to treat BP-related diseases on account of expanding healthcare costs is creating a positive outlook for the market. Besides this, there is a rise in the number of online retail platforms that offer antihypertensive drugs according to the dosage needed by the consumer. This, along with significant growth in the pharmaceutical and e-commerce industries, is propelling the growth of the market. Additionally, the increasing adoption of health insurance policies that provide financial assistance for hypertension treatment and minimize healthcare expenses is impelling the growth of the market.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global antihypertensive drugs market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on therapeutic class, type and distribution channel.
Therapeutic Class Insights:
- Diuretics
- ACE Inhibitors
- Calcium Channel Blockers
- Beta-adrenergic Blockers
- Vasodilators
- Others
Type Insights:
- Primary Hypertension
- Secondary Hypertension
Distribution Channel Insights:
- Retail Pharmacy
- Hospital Pharmacy
- E-Commerce
Regional Insights:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The report has also provided a comprehensive analysis of the competitive landscape in the global antihypertensive drugs market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include AstraZeneca, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Johnson & Johnson Services Inc., Lupin Pharmaceuticals Inc, Merck & Co. Inc., Novartis AG, Pfizer Inc., Sanofi, Sun Pharmaceutical Industries Ltd., etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Questions Answered in This Report:
- How has the global antihypertensive drugs market performed so far, and how will it perform in the coming years?
- What are the drivers, restraints, and opportunities in the global antihypertensive drugs market?
- What is the impact of each driver, restraint, and opportunity on the global antihypertensive drugs market?
- What are the key regional markets?
- Which countries represent the most attractive antihypertensive drugs market?
- What is the breakup of the market based on the therapeutic class?
- Which is the most attractive therapeutic class in the antihypertensive drugs market?
- What is the breakup of the market based on the type?
- Which is the most attractive type in the antihypertensive drugs market?
- What is the breakup of the market based on the distribution channel?
- Which is the most attractive distribution channel in the antihypertensive drugs market?
- What is the competitive structure of the global antihypertensive drugs market?
- Who are the key players/companies in the global antihypertensive drugs market?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPEUTIC CLASS
6.1 Diuretics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 ACE Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Calcium Channel Blockers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Beta-adrenergic Blockers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Vasodilators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY TYPE
7.1 Primary Hypertension
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Secondary Hypertension
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 E-Commerce
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Boehringer Ingelheim International GmbH
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson Services Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Lupin Pharmaceuticals Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL ANTIHYPERTENSIVE DRUGS MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Forecast
6 MARKET BREAKUP BY THERAPEUTIC CLASS
6.1 Diuretics
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 ACE Inhibitors
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Calcium Channel Blockers
6.3.1 Market Trends
6.3.2 Market Forecast
6.4 Beta-adrenergic Blockers
6.4.1 Market Trends
6.4.2 Market Forecast
6.5 Vasodilators
6.5.1 Market Trends
6.5.2 Market Forecast
6.6 Others
6.6.1 Market Trends
6.6.2 Market Forecast
7 MARKET BREAKUP BY TYPE
7.1 Primary Hypertension
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Secondary Hypertension
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY DISTRIBUTION CHANNEL
8.1 Retail Pharmacy
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Hospital Pharmacy
8.2.1 Market Trends
8.2.2 Market Forecast
8.3 E-Commerce
8.3.1 Market Trends
8.3.2 Market Forecast
9 MARKET BREAKUP BY REGION
9.1 North America
9.1.1 United States
9.1.1.1 Market Trends
9.1.1.2 Market Forecast
9.1.2 Canada
9.1.2.1 Market Trends
9.1.2.2 Market Forecast
9.2 Asia-Pacific
9.2.1 China
9.2.1.1 Market Trends
9.2.1.2 Market Forecast
9.2.2 Japan
9.2.2.1 Market Trends
9.2.2.2 Market Forecast
9.2.3 India
9.2.3.1 Market Trends
9.2.3.2 Market Forecast
9.2.4 South Korea
9.2.4.1 Market Trends
9.2.4.2 Market Forecast
9.2.5 Australia
9.2.5.1 Market Trends
9.2.5.2 Market Forecast
9.2.6 Indonesia
9.2.6.1 Market Trends
9.2.6.2 Market Forecast
9.2.7 Others
9.2.7.1 Market Trends
9.2.7.2 Market Forecast
9.3 Europe
9.3.1 Germany
9.3.1.1 Market Trends
9.3.1.2 Market Forecast
9.3.2 France
9.3.2.1 Market Trends
9.3.2.2 Market Forecast
9.3.3 United Kingdom
9.3.3.1 Market Trends
9.3.3.2 Market Forecast
9.3.4 Italy
9.3.4.1 Market Trends
9.3.4.2 Market Forecast
9.3.5 Spain
9.3.5.1 Market Trends
9.3.5.2 Market Forecast
9.3.6 Russia
9.3.6.1 Market Trends
9.3.6.2 Market Forecast
9.3.7 Others
9.3.7.1 Market Trends
9.3.7.2 Market Forecast
9.4 Latin America
9.4.1 Brazil
9.4.1.1 Market Trends
9.4.1.2 Market Forecast
9.4.2 Mexico
9.4.2.1 Market Trends
9.4.2.2 Market Forecast
9.4.3 Others
9.4.3.1 Market Trends
9.4.3.2 Market Forecast
9.5 Middle East and Africa
9.5.1 Market Trends
9.5.2 Market Breakup by Country
9.5.3 Market Forecast
10 SWOT ANALYSIS
10.1 Overview
10.2 Strengths
10.3 Weaknesses
10.4 Opportunities
10.5 Threats
11 VALUE CHAIN ANALYSIS
12 PORTERS FIVE FORCES ANALYSIS
12.1 Overview
12.2 Bargaining Power of Buyers
12.3 Bargaining Power of Suppliers
12.4 Degree of Competition
12.5 Threat of New Entrants
12.6 Threat of Substitutes
13 PRICE ANALYSIS
14 COMPETITIVE LANDSCAPE
14.1 Market Structure
14.2 Key Players
14.3 Profiles of Key Players
14.3.1 AstraZeneca
14.3.1.1 Company Overview
14.3.1.2 Product Portfolio
14.3.1.3 Financials
14.3.1.4 SWOT Analysis
14.3.2 Boehringer Ingelheim International GmbH
14.3.2.1 Company Overview
14.3.2.2 Product Portfolio
14.3.3 Daiichi Sankyo Company Limited
14.3.3.1 Company Overview
14.3.3.2 Product Portfolio
14.3.3.3 Financials
14.3.3.4 SWOT Analysis
14.3.4 Johnson & Johnson Services Inc.
14.3.4.1 Company Overview
14.3.4.2 Product Portfolio
14.3.4.3 Financials
14.3.4.4 SWOT Analysis
14.3.5 Lupin Pharmaceuticals Inc
14.3.5.1 Company Overview
14.3.5.2 Product Portfolio
14.3.6 Merck & Co. Inc.
14.3.6.1 Company Overview
14.3.6.2 Product Portfolio
14.3.6.3 Financials
14.3.6.4 SWOT Analysis
14.3.7 Novartis AG
14.3.7.1 Company Overview
14.3.7.2 Product Portfolio
14.3.7.3 Financials
14.3.7.4 SWOT Analysis
14.3.8 Pfizer Inc.
14.3.8.1 Company Overview
14.3.8.2 Product Portfolio
14.3.8.3 Financials
14.3.8.4 SWOT Analysis
14.3.9 Sanofi
14.3.9.1 Company Overview
14.3.9.2 Product Portfolio
14.3.9.3 Financials
14.3.9.4 SWOT Analysis
14.3.10 Sun Pharmaceutical Industries Ltd.
14.3.10.1 Company Overview
14.3.10.2 Product Portfolio
14.3.10.3 Financials
14.3.10.4 SWOT Analysis
LIST OF TABLES
Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
Table 7: Global: Antihypertensive Drugs Market: Key Players
Table 1: Global: Antihypertensive Drugs Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Antihypertensive Drugs Market Forecast: Breakup by Therapeutic Class (in Million US$), 2024-2032
Table 3: Global: Antihypertensive Drugs Market Forecast: Breakup by Type (in Million US$), 2024-2032
Table 4: Global: Antihypertensive Drugs Market Forecast: Breakup by Distribution Channel (in Million US$), 2024-2032
Table 5: Global: Antihypertensive Drugs Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Antihypertensive Drugs Market: Competitive Structure
Table 7: Global: Antihypertensive Drugs Market: Key Players
LIST OF FIGURES
Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2023
Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2023
Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Antihypertensive Drugs (Primary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Antihypertensive Drugs (Primary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis
Figure 1: Global: Antihypertensive Drugs Market: Major Drivers and Challenges
Figure 2: Global: Antihypertensive Drugs Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Antihypertensive Drugs Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Antihypertensive Drugs Market: Breakup by Therapeutic Class (in %), 2023
Figure 5: Global: Antihypertensive Drugs Market: Breakup by Type (in %), 2023
Figure 6: Global: Antihypertensive Drugs Market: Breakup by Distribution Channel (in %), 2023
Figure 7: Global: Antihypertensive Drugs Market: Breakup by Region (in %), 2023
Figure 8: Global: Antihypertensive Drugs (Diuretics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Antihypertensive Drugs (Diuretics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Antihypertensive Drugs (ACE Inhibitors) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Antihypertensive Drugs (ACE Inhibitors) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Antihypertensive Drugs (Calcium Channel Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Antihypertensive Drugs (Beta-adrenergic Blockers) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Antihypertensive Drugs (Vasodilators) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Antihypertensive Drugs (Vasodilators) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Antihypertensive Drugs (Other Therapeutic Classes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Antihypertensive Drugs (Primary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Antihypertensive Drugs (Primary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Antihypertensive Drugs (Secondary Hypertension) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Antihypertensive Drugs (Secondary Hypertension) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Antihypertensive Drugs (Retail Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Antihypertensive Drugs (Retail Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Antihypertensive Drugs (Hospital Pharmacy) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Antihypertensive Drugs (Hospital Pharmacy) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Antihypertensive Drugs (E-Commerce) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Antihypertensive Drugs (E-Commerce) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: North America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: North America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: United States: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: United States: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Canada: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Canada: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Asia-Pacific: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Asia-Pacific: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: China: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: China: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: Japan: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: Japan: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: India: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: India: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: South Korea: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: South Korea: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: Australia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: Australia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Indonesia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Indonesia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: Europe: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: Europe: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Germany: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Germany: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: France: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: France: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: United Kingdom: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: United Kingdom: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Italy: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Italy: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Spain: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Spain: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: Russia: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: Russia: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Latin America: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Latin America: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Brazil: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Brazil: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Mexico: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Mexico: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Middle East and Africa: Antihypertensive Drugs Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Middle East and Africa: Antihypertensive Drugs Market: Breakup by Country (in %), 2023
Figure 78: Middle East and Africa: Antihypertensive Drugs Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 79: Global: Antihypertensive Drugs Industry: SWOT Analysis
Figure 80: Global: Antihypertensive Drugs Industry: Value Chain Analysis
Figure 81: Global: Antihypertensive Drugs Industry: Porter's Five Forces Analysis
